Review Articles

Everts PA, Knape, JT, Weibrich G, Schonberger JP,, Hoffman J, Overdest EP, Box H, van Zundert A, Platelet-rich Plasma and Platelet Gel: A Review, JECT:2006;38; 174-187:
 
Prospective Studies

Driver V, Hanft J, Fylling C, Beriou J, AutoloGel™ Diabetic Foot Ulcer Study Group. A Prospective, Randomized, Controlled Trial of Autologous Platelet-Rich Plasma Gel versus Control for the Treatment of Diabetic Foot Ulcers. Ostomy/Wound Management. 2006; 52(6): 68-87.

Saldalamacchia G, Lapice E, Cuomo V, De Feo E, D’Agostino E, Rivellese AA, Vaccaro O, A controlled study of the use of autologous platelet gel for the treatment of diabetic foot ulcers. Nutr Metab Cardiovasc Dis. 2004 Dec; 14(6):395-6

Holloway GA, Steed DL, DeMarco MJ, et al. A randomized, controlled dose response trial of activated platelet supermatant, topical CT-102 in chronic, nonhealing, diabetic wounds. Wounds. 1993;5:160-168.

Steed DL, Goslen JB, Holloway GA, et al. Randomized, double blind trial in healing of chronic diabetic foot ulcers: CT-102 activated platelet supernatant, topical versus placebo. Diabetes Care. 1992;15:1598-1604.

Knighton DR, Ciresi K, Fiegel VD, et al. Stimulation of repair in chronic nonhealing cutaneous ulcers: a prospectively randomized blinded trial using platelet-derived wound healing formula. Surg Gynecol Obstet. 1990;170:56-60.

Atri SC, Misra J, Bisht D, et al. Use of homologous platelet factors in achieving total healing of recalcitrant skin ulcers. Surgery. 1990;108: 508-512


Retrospective Studies
 
Margolis DJ, Kantor J, Santanna J, et al. Effectiveness of Platelet Releasate for the Treatment of Diabetic Neuropathic Foot Ulcers. Diabetes Care. 2001;24:483-488.

Fylling CP, Baxter CR, Bennett KG, et al. Multi-center clinical review: Using autologous platelet gel for the treatment of diabetic plantar wounds. Diabetes. 2001(S2);50:229A.

Glover JL, Weingarten MS, Buchbinder DS, et al. A four-year multicenter retrospective study of topical multiple growth factor therapy for chronic wounds. Adv Wound Care. 1997;10(1):27-32.

Keyser, JE. Diabetic wound healing and limb salvage in an outpatient wound care program. South Med Jour. 1993;86:311-317.

Fylling, CP. A five center study of diabetic wound healing in comprehensive wound management programs. Diabetes. 1992(S);41:82A

Knighton DR, Fylling CP, Fiegel VD, et al. Amputation prevention in an independently reviewed at-risk diabetic population using a comprehensive wound care protocol. Amer J Surg. 1990;160:466-472.

Fylling CP, Knighton DR, Gordinier RH. The use of a comprehensive wound care protocol including topical growth factor therapy in treatment of diabetic neuropathic ulcers. In: Ward J and Goto Y. Diabetic Neuropathy. New York: John Wiley & Sons; 1990:567-578.

Doucette MM, Fylling CP, Knighton DR. Amputation Prevention in a high-risk population through a comprehensive wound healing protocol. Arch Phys Med Rehabil. 1989;70:780-785.

Knighton DR, Fylling CP, Doucette MM. Wound healing and amputation in a high-risk diabetic population. Wounds. 1989;2:107-114.

Knighton DR, Ciresi KF, Fiegel VD, et al. Classification and treatment of chronic nonhealing wounds: successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg. 1986;3:322-330..

Cost Effectiveness Studies

Bentkover JF, Champion AH. Economic evaluation of alternative methods of treatment for diabetic foot ulcer patients: cost effectiveness of platelet releasate and wound care clinics. Wounds. 1993;5:207-215.

Fylling CP, McKeown PC. Cost and healing efficacy of treating diabetic foot ulcers in a comprehensive wound management program with growth factor therapy. Diabetes. 1990(S);39:18A.